合成,在体外胆酶抑制,分子对接,密度功能理论分析的本齐米达基水 Schiff 基
Naqib Ahmad1, Nida Ambreen1, Muhammad Ayaz2
1Department of Chemistry, Abdul Wali Khan University, Mardan, Khyber Pakhtunkhwa, Pakistan.
新的本齐米达衍生物显示出强大的乙胆酶 (AChE) 和丁胆酶 (BuChE) 的双重抑制,这是阿尔茨海默病治疗的关键标. 甲基团增强抑制活性和结合亲和力,表明有前途的治疗潜力.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 有机合成 有机合成
背景情况:
- 乙胆酶 (AChE) 和丁胆酶 (BuChE) 是阿尔茨海默氏症等神经退行性疾病的关键治疗点.
- 开发具有增强疗效和特异性的新型抑制剂对于有效治疗至关重要.
研究的目的:
- 为了合成新型的酸,胺的希夫基衍生物.
- 评估它们在体外对 AChE 和 BuChE 的抑制活性.
- 调查结构-活动关系和约束机制.
主要方法:
- 合成本齐米达衍生物.
- 在体外酶抑制试验 (AChE和BuChE).
- 使用HR-ESI-MS,1H-NMR和13C-NMR进行结构阐明.
- 分子对接,TD-DFT和分子动力学 (MD) 模拟.
主要成果:
- 合成的化合物表现出明显的双重抑制潜力,对抗ACHE和BuChE.
- 含有甲氧基的化合物 (7),表现出显著的电子性质和强的双结合.
- 模拟MD揭示化合物 (7) 诱导形状变化有效的双重抑制.
结论:
- 合成的本齐米达衍生物显示出作为强大的胆酶抑制剂的前景.
- 甲基组对于增强抑制活性和双结合至关重要.
- 这些发现支持开发用于阿尔茨海默病的新型治疗剂.
更多相关视频
03:29Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
Published on: May 31, 2024
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Directing and Steric Effects in Disubstituted Benzene Derivatives
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Diazonium Group Substitution: –OH and –H
